Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Cancer Guidelines
    • Chemoembolization for...

    Chemoembolization for unresectable hepatocellular carcinoma(HCC)-Standard Treatment Guidelines

    Written by supriya kashyap kashyap Published On 2017-09-12T15:10:34+05:30  |  Updated On 10 Aug 2021 1:07 PM IST

    Introduction


    The treatment of choice for HCC remains surgical resection or liver transplanation, however, in a non-surgical case a variety of percutaneous therapeutic interventional palliative treatment techniques such as transcatheter arterial chemoembolization (TACE), transcatheter arterial radio- embolization (TART) and percutaneous ablative therapies like radiofrequency ablation (RFA) are available (1- 3).

    Ministry of Health and Family Welfare, Government of India has issued the Standard Treatment Guidelines for Chemoembolization for unresectable hepatocellular carcinoma(HCC).
    Following are the major recommendations :

    Case definition
    For both situations of care (mentioned below)


    A clinically or radiologically suspected, biopsy or laboratory proved case of hepatocellular carcinoma.

    INCIDENSE OF THE CONDITION IN OUR COUNTRY


    HCC is one of the common cancer and the cause of cancer related death in the world. It's incidence in India is also increasing due to increase in incidence of cirrhosis and hepatitis B&C.


    DIFFERENTIAL DIAGNOSIS-Liver metastasis, benign hepatic lesion.


    PREVENTION AND COUNSELLING-Since HBV is the most common etiologic agent in our country, the vaccination against hepatitis B may be an effective preventive strategy.


    The other cause such as alcohol induced cirrhosis may be avoided by avoidance of alcohol.


    Proper counseling of patient by explaining him various non-surgical interventional treatment options and their outcome should be explained to every patient.


    OPTIMAL DIAGNOSTIC CRITERIA, INVESTIGATIONS, TREATMENT & REFERRAL CRITERIA :


    Diagnostic criteria / investigations-


    Clinical -features of cirrhosis & palpable mass.
    Biochemical -Serum alpha fetoprotein (AFP), viral markers (HBV & HCV)
    Radiological - Imaging features on US, CT & MR.
    Histological - Fine needle aspiration cytology or biopsy as & when required.


    Treatment-Chemoembolization for unresectable tumour with child's class A & B.




    1. Tumour size > 5 cm in diameter.

    2. Tumour size > 3 cm in diameter and 2 or 3 in number.

    3. Treatable size tumour with ipsilateral portal vein invasion.


    Referral criteria-

    Patient fit for chemoembolization is treated with angiographic treatment. If angiographic facility is not available at the hospital, patient is referred to the hospital with such treatment facilities.

    Situation 1 : At Secondary Hospital / Non-Metro situation : Optimal Standards of Treatment in situations where technology and resources are limited.


    Clinical Diagnosis: Clinical features of cirrhosis &/or palpable mass.
    Investigations :
    Biochemical- Serum alpha fetoprotein (AFP), viral markers (HBV & HCV)
    Radiological- Imaging features on US, CT & MR.
    Histological- Fine needle aspiration cytology or biopsy as & when required.

    Treatment : chemoembolization for unresectable tumour with
    Child's class A & B.

    Standard operating procedure

    In Patient - Chemoembolization is performed as indoor case
    Out Patient - Not applicable
    Day Care - Not applicable

    Referral criteria :

    If facilities for standard treatment are not available, patient is referred to super specialty hospital where these facilities are available.

    Situation 2 : At super specialty facility in metro location where higher-end technology is available.


    Clinical Diagnosis :Clinical features of cirrhosis &/or palpable mass.


    Investigations :Biochemical – Serum alpha fetoprotein (AFP), viral markers (HBV & HCV)
    Radiological – Imaging features on US, CT & MR.
    Histological – Fine needle aspiration cytology or biopsy as & when required.


    Treatment : Chemoembolization for unresectable tumour with Child's class A & B.


    Standard operating procedure


    In Patient - Chemoembolization is performed as indoor case
    Out Patient - Not applicable
    Day Care - Not applicable
    Referral criteria : Not applicable


    RESOURCES REQUIRED FOR ONE PATIENT / PROCEDURE (PATIENT WEIGHT 60 KGS)


    (Units to be specified for human resources, investigations, drugs and consumables and equipment. Quantity to also be specified)
























    SITUATIONHUMAN RESOURCESINVESTIGATIONSDRUGS & CONSUMABLESEQUIPMENT
    1.(Radiologists-2 Anaesthetist -1 Clinician - 1) Technicians –2 Nurses – 2 Orderly / Ward Boy - 21. Routine blood

    examination

    Hb, TLC, DLC etc.

    2. S. alfa feto protein

    3. Serum HBV &

    HCV

    4. Liver function

    tests

    5. Blood sugar etc
    1. Doxorubicin

    50 – 100 mg.

    2. Other chemotherapeutic

    drugs

    as per case

    3. Lipiodol 20 ml

    4. Angiographic

    catheters (4 –5 F)

    5. Microcatheter

    (3F)

    6. Gel foam

    7. PVA 3/4 vials

    Digital

    subtraction

    angiography

    equipment

    with life

    saving devices

    and

    Ultrasound

    (colour

    Doppler)

    equipment
    2.Same as mentioned aboveSame as mentioned aboveSame as mentioned aboveSame as mentioned above

    Guidelines by The Ministry of Health and Family Welfare :

    Dr. Chander Mohan
    Dr. B.L. Kapur Hospital
    New Delhi
    carcinomaDr Chander MohanguidelinesHepatocellular Carcinomatreatment guidelines

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok